BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8885619)

  • 1. Development of life-threatening thrombocytopaenia in a patient on MDT and prednisolone.
    Croft R
    Lepr Rev; 1996 Sep; 67(3):229. PubMed ID: 8885619
    [No Abstract]   [Full Text] [Related]  

  • 2. Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
    Goulart IM; Reis AC; De Rezende TM; Borges AS; Ferreira MS; Nishioka SA
    Lepr Rev; 2005 Jun; 76(2):167-9. PubMed ID: 16038251
    [No Abstract]   [Full Text] [Related]  

  • 3. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immuno-allergic accidents with rifamipcin].
    Flageul B; Wagner L; Cottenot F
    Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifampicin-induced erythema nodosum leprosum-like eruption in borderline lepromatous leprosy.
    Karthikeyan K; Thappa DM; Kadhiravan T
    Indian J Lepr; 2001; 73(2):167-9. PubMed ID: 11579653
    [No Abstract]   [Full Text] [Related]  

  • 6. A rare variant of erythema nodosum leprosum: a case report.
    Dave S; Thappa DM; Nori AV; Jayanthi S
    Dermatol Online J; 2003 Dec; 9(5):11. PubMed ID: 14996384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recurrent lepromatous leprosy in conventional triple therapy: value of the rifampicin-ofloxacin combination].
    Marlier S; Carsuzaa F; De Jaureguiberry JP; Galzin M; Carloz E; Carli P; Chagnon A
    Med Trop (Mars); 1995; 55(2):182. PubMed ID: 7565004
    [No Abstract]   [Full Text] [Related]  

  • 8. Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.
    Naafs B
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S21-8. PubMed ID: 9030120
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythema leprosum--after treatment of Lepromatous Leprosy.
    Eickelmann M; Steinhoff M; Metze D; Tomimori-Yamashita J; Sunderkötter C
    J Dtsch Dermatol Ges; 2010 Jun; 8(6):450-3. PubMed ID: 19922466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dapsone-induced motor polyneuropathy in a patient with leprosy.
    Pavithran K; Satish TC
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):262-3. PubMed ID: 9251603
    [No Abstract]   [Full Text] [Related]  

  • 11. Histoid leprosy with erythema nodosum leprosum--a case report.
    Vasavi S; Reddy BS
    Indian J Lepr; 2012; 84(1):27-9. PubMed ID: 23077781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lucio leprosy with lucio phenomenon.
    Saoji V; Salodkar A
    Indian J Lepr; 2001; 73(3):267-72. PubMed ID: 11840599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serious side effects of rifampin on the course of WHO/MDT: a case report.
    Namisato M; Ogawa H
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):277-82. PubMed ID: 11221090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How should leprosy be treated?].
    Mahé A
    Ann Dermatol Venereol; 1998 Dec; 125(12):881-3. PubMed ID: 9922859
    [No Abstract]   [Full Text] [Related]  

  • 15. Lepromatous leprosy with drug reaction.
    Baxt RD
    Dermatol Online J; 2000 Sep; 6(1):9. PubMed ID: 11328619
    [No Abstract]   [Full Text] [Related]  

  • 16. Rate of decline in bacterial index in leprosy; observations after three different chemotherapeutic interventions.
    Ganapati R; Pai VV; Shroff HJ; Gandewar K
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):264-6. PubMed ID: 9251604
    [No Abstract]   [Full Text] [Related]  

  • 17. Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy.
    Rea TH
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):129-35. PubMed ID: 11036492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histoid leprosy; report of three cases.
    Krishna KK
    Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):174-6. PubMed ID: 10472376
    [No Abstract]   [Full Text] [Related]  

  • 19. Disseminated intravascular coagulopathy as an adverse reaction to intermittent rifampin schedule in the treatment of leprosy.
    Souza CS; Alberto FL; Foss NT
    Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):366-71. PubMed ID: 9401490
    [No Abstract]   [Full Text] [Related]  

  • 20. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
    Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.